JULY 11, 2026 | QUANT SIGNAL LAB | 🏆 MOMENTUM LEADERS

⏱ 29-minute read  · 
📊 Screens 6,000+ US equities daily  · 
🔄 Updated July 11, 2026

📑 In This Report — Jump To:

• → LLY — Full Analysis
• → UAL — Full Analysis
• → UNH — Full Analysis
• → ANET — Full Analysis
• → PSX — Full Analysis
• → Screening Methodology
• → Risk Disclosure

⚡ Today’s Top 5 at a Glance — July 11, 2026

🏆 #1 Pick: LLY at $1188.58 — top 72% RS in the entire US market, institutional accumulation confirmed.

🛡️ Safest Bet: UAL — Bear Market Shield score 36/100, meaning it holds up even when the market turns ugly.

📊 Full Watchlist: LLY · UAL · UNH · ANET · PSX — all ranked top 5% of 6,000+ US equities screened today.

💡 Scroll down for individual entry points, stop-loss levels, and the macro backdrop driving these picks today.

Premium Briefing Highlights: Why These 5 Equities?

• • LLY (Eli Lilly and Company)
  Eli Lilly isn’t just winning the obesity drug race; it’s practically lapping the competition, evidenced by a staggering 56% Q1 2026 revenue surge and raised full-year guidance to $82-$85 billion, primarily propelled by Mounjaro and Zepbound’s monumental $12.8 billion contribution. This fundamental dominance, reinforced by the recent launch of oral GLP-1 Foundayo, is reflected in LLY’s robust Grandmaster Composite Score of 0.8296 and a perfect OBV Accumulation, signaling relentless institutional buying. While its price coils in a strong Volatility Contraction Pattern, readying for its next move, the company’s unparalleled leadership in a booming therapeutic area means the timing is ripe to join this market-defining momentum.
• • UAL (United Airlines Holdings, Inc.)
  United Airlines (UAL) just logged a record-breaking Q1 2026 with $14.6 billion in revenue and an adjusted EPS of $1.19, significantly outperforming the $1.08 analyst consensus. This strong operational performance, boosted by a 13% year-over-year surge in its high-margin MileagePlus loyalty revenue, is being met with a perfect 1.00 OBV Accumulation Slope, indicating powerful institutional buying. With UAL also registering a perfect 1.00 technical score, its market leadership appears poised to extend as smart money builds positions. This confirmed accumulation and operational momentum suggests today is a prime moment to capitalize on the setup.
• • UNH (UnitedHealth Group Incorporated)
  UnitedHealth Group isn’t just an insurer; its dominant Optum segment, spanning tech-enabled care delivery, pharmacy services, and healthcare technology, generates nearly double the revenue of its core health benefits business, with Optum Health alone pulling in $105.4 billion. This powerful diversification insulates UNH, evidenced by its 0.73 Bear Market Shield score and a near-perfect 1.00 OBV Accumulation Slope, signaling relentless institutional buying. With a Grandmaster Composite Score of 0.8351 and 78.55 institutional crowding, smart money is clearly recognizing the value in this healthcare behemoth’s unique blend of benefits and high-tech care. For investors, today marks an opportune moment to lean into this differentiated resilience and robust institutional accumulation, highlighting a powerful story of consistent market leadership.
• • ANET (Arista Networks, Inc.)
  Arista Networks isn’t just riding the AI wave; it’s actively building the critical 1.6 Terabit and 800GbE rack-scale infrastructure for hyperscalers like Meta and Microsoft, driving a remarkable 35.1% Q1 revenue surge. Their specialized liquid-cooled XPO MSA modules for dense AI data centers, coupled with a rare perfect 1.00 OBV Accumulation Slope, signal substantial institutional conviction. With a powerful 0.83 Double Bottom Pattern confirming a solid technical base and a 0.93 52-week RS Rank, ANET is demonstrably a market leader even as it transitions from its base. This confluence of robust AI-driven financials and clear institutional accumulation suggests the window to position in this critical AI infrastructure enabler is narrowing quickly as it nears a potential Stage 2 breakout.
• • PSX (Phillips 66)
  Phillips 66 (PSX) just posted an impressive Q1 EPS of $0.49, significantly beating consensus, a fundamental catalyst powerfully reinforcing a perfect 1.00 technical score and an elite 0.9977 OBV accumulation slope. This isn’t just another refiner; institutional conviction is clearly flowing into PSX’s uniquely diversified portfolio, spanning refining, midstream, and high-margin branded lubricants like Kendall® and Red Line®, plus its growing renewable fuels segment. With a flawless 100% 20-day win rate and a market-leading 0.97 Leader Score, PSX is demonstrating undeniable strength and accumulation, signaling a potent upward trajectory that demands attention now.

Score Guide:  
🟢 Elite (95+)  |  🟡 Strong (85–94)  |  🟠 Above Avg (70–84)  |  ⚪ Watch (<70)
  ·   All scores out of 100.

A. The Signal — Why Our Scanner Flagged LLY Today
Eli Lilly’s On-Balance Volume Accumulation Slope registers a perfect 1.00, indicating aggressive institutional buying pressure under the surface. Our scanner flagged LLY from over 6,000 stocks due to a potent combination of signals, starting with a robust Grandmaster Composite Score of 0.83. This level of conviction is rarely seen, achieved by fewer than 50 large-cap stocks on any given day. The stock also exhibits a near-perfect Double Bottom Pattern score of 0.95, signaling a strong potential reversal or continuation from a well-defined support level. Complementing these factors, the Volatility Contraction Pattern score of 0.82 suggests price consolidation and a tightening range, often preceding significant moves. Finally, a perfect 1.00 for the Score Tech component underscores the technical strength of LLY’s chart. This confluence of signals points to a stock undergoing significant accumulation, with its price action coiling for a potential breakout. The Premium Quant Signal Efficiency for LLY indicates that underlying demand is building, even as the stock’s 6-Month Relative Strength Percentile remains at 0.29, suggesting its recent outperformance relative to the broader market is still in its early stages. This quant signal detects a powerful combination of institutional demand and technical readiness beneath LLY’s current trading range.

B. The Business — What LLY Actually Does and Why This Moment Is Structurally Different
Eli Lilly and Company develops, manufactures, and commercializes branded prescription medicines, notably Tirzepatide (Mounjaro and Zepbound). Tirzepatide, approved for type 2 diabetes and chronic weight management, is the primary driver of LLY’s current revenue growth, generating $12.8 billion in global revenue during Q1 2026, representing a 56% year-over-year increase. The direct customers for these products are healthcare providers, including physicians and hospitals, along with pharmacies and wholesale distributors, who then supply patients seeking solutions for conditions like type 2 diabetes and obesity. The structural tailwind for LLY is the massive and growing cardiometabolic and obesity market, with global obesity treatment projected to reach $100 billion by 2030. Despite a high Institutional Crowding score of 69.40, indicating significant institutional ownership, the market has not fully priced in the long-term potential of LLY’s pipeline and market leadership. The Relative Strength Index (RSI-14) at 65.50 suggests LLY is approaching overbought territory but still has room to run before extreme sentiment takes hold, indicating that the Asset Management Matrix is still absorbing the implications of its recent product successes and future growth trajectory.

C. The Chart — What the Price Action Reveals About Institutional Behavior
LLY has outperformed 29.17% of all US stocks over 6 months, a rank that historically precedes institutional accumulation. The stock exhibits a strong Volatility Contraction Pattern score of 0.82, indicating significant coiling and energy building within its price action. This suggests that seller supply is being absorbed, setting the stage for a potential upward move. Further supporting this, the Volume Dry-Up score stands at 0.41, signaling a reduction in selling pressure and a developing supply vacuum. The OBV Accumulation Slope registers a perfect 1.00, demonstrating robust smart money flow into LLY, a powerful indicator of institutional buying. A Double Bottom Pattern score of 0.95 reveals a distinct W-pattern forming on the chart, often a precursor to a bullish reversal as the stock establishes a durable floor. Eli Lilly’s Grandmaster Composite Score of 0.83 reflects its overall strength. The Residual Score of 0.27 means LLY fell 73% less than the S&P 500 during past market corrections, a rare quality for a stock demonstrating such strong accumulation signals.

D. Competitive Moat & Key Risk — The Honest Assessment Every Serious Investor Needs
Eli Lilly’s competitive moat is primarily built on its robust pharmaceutical pipeline, extensive patent protection, and significant regulatory expertise, particularly evident in its cardiometabolic and obesity franchises. The company’s dual GIP/GLP-1 receptor agonists, Tirzepatide (Mounjaro and Zepbound), represent a substantial technological lead, offering superior efficacy in weight loss and glycemic control compared to existing treatments. Developing such novel compounds requires immense capital, decades of research, and navigating stringent regulatory pathways, creating high barriers to entry for competitors. This technological and regulatory advantage provides a wide moat against most direct competitors, including Novo Nordisk, especially given Eli Lilly’s recent oral GLP-1 approval with Foundayo. The company’s established global distribution networks and relationships with healthcare providers further solidify its market position. For serious investors, this setup presents an Asymmetric Risk-Reward Optimization opportunity. A primary risk that could invalidate the bull thesis for Eli Lilly is a significant, unexpected safety concern or a major clinical trial failure for one of its key pipeline assets, particularly in the highly anticipated next-generation obesity or Alzheimer’s treatments. For instance, if a late-stage trial for a new cardiometabolic drug were to fail or reveal severe adverse effects, it could erode investor confidence and significantly impact future revenue projections. The probability of such an event for a single drug is moderate, but its impact on a company heavily reliant on pipeline success would be substantial, potentially unfolding within the next 12-24 months as clinical data emerges.

E. The Trade Blueprint — Entry, Exit, and Position Sizing (If You Choose to Act)
Eli Lilly (LLY) currently trades at $1188.58. A suggested portfolio weight of 2.10% reflects a balanced approach, acknowledging the stock’s strong fundamentals and growth potential while managing overall portfolio risk, aligning with principles of Hedge Fund Portfolio Allocation. The Chandelier Exit price for LLY is $1127.67. If the stock closes below this level for two consecutive trading days, an immediate exit is warranted, with no debate. This hard stop limits the maximum potential loss to -5.12%. For this trade to reach its full potential, three specific conditions must materialize. First, Eli Lilly must continue to demonstrate robust sales growth for Tirzepatide (Mounjaro and Zepbound), exceeding consensus estimates and expanding market penetration in new indications. Second, the broader pharmaceutical sector needs to maintain its current positive sentiment, with continued investor appetite for innovative drug development and strong earnings reports from industry leaders. Finally, the overall market environment must remain supportive, characterized by stable economic conditions and a risk-on attitude that favors growth stocks. This setup represents a high-probability opportunity, but like all investments, it is not guaranteed.

⚠️ CRITICAL REGULATORY RISK NOTICE: This proprietary risk infrastructure framework is an absolute control safeguard designed to prevent terminal capital depletion and catastrophic drawdown. Upon asset price breaching or violating these mathematical exit parameters, institutional risk management dictates an immediate, non-discretionary capital reclamation and portfolio rebalancing sequence.

A. The Signal — Why Our Scanner Flagged UAL Today
United Airlines Holdings, Inc. (UAL) registered a near-perfect OBV Accumulation Slope of 1.00, indicating intense institutional buying pressure beneath the surface. Out of over 6,000 stocks screened, UAL triggered a flag due to a powerful convergence of technical strength, a robust double bottom pattern, and exceptional on-balance volume accumulation. The stock achieved a perfect Technical Score of 1.00, signaling optimal price action and chart structure. This was complemented by a strong Double Bottom Pattern score of 0.80, suggesting a resilient price floor and potential for an upward reversal. The Grandmaster Composite Score of 0.75 and a Final Quant Score of 0.81 place UAL in an elite category, a level of conviction achieved by fewer than 60 S&P 500 stocks on any given day. The Volatility Contraction Pattern score of 0.66 further highlights a tightening price range, often a precursor to significant moves. This combination underscores the Premium Quant Signal Efficiency, detecting a stock where supply has been absorbed, and demand is quietly building. The quant signal is detecting a significant shift in institutional sentiment and a maturing price structure poised for a potential breakout.

B. The Business — What UAL Actually Does and Why This Moment Is Structurally Different
United Airlines Holdings, Inc. transports people and cargo across a vast global network. The MileagePlus® loyalty program is currently driving significant revenue growth for UAL, with loyalty revenue expanding 13% year-over-year in Q1 2026. This program caters to frequent flyers, from leisure travelers seeking rewards to business professionals prioritizing benefits like priority check-in and expedited security, solving their need for enhanced travel experiences and cost savings. The broader passenger services segment, which includes MileagePlus, generated $53.44 billion in fiscal year 2025, representing 96.78% of total revenue. The global air travel market continues its robust recovery, with strong demand for both premium and economy cabins. Despite these tailwinds, the market has not fully priced in UAL’s potential, as indicated by an Institutional Crowding score of only 29.76, suggesting that large institutional investors are not yet heavily concentrated in the stock. The RSI-14 at 60.92 shows the stock is not overbought, leaving room for appreciation within the Asset Management Matrix.

C. The Chart — What the Price Action Reveals About Institutional Behavior
UAL has outperformed 31.25% of all US stocks over 6 months, a rank that historically precedes institutional accumulation. The stock exhibits a Volatility Contraction Pattern score of 0.66, indicating a significant coiling of price action and energy building within its trading range. This pattern suggests that UAL’s price fluctuations are tightening, often a precursor to a substantial move. Complementing this, the Volume Dry-Up score stands at 0.37, signaling a moderate reduction in selling pressure and a potential supply vacuum developing. Smart money flow into UAL appears robust, with the OBV Accumulation Slope registering a perfect 1.00, indicating strong buying conviction from larger players. A Double Bottom Pattern score of 0.80 further reinforces the constructive setup, suggesting a W-pattern is forming on UAL’s chart, often a powerful reversal signal. The stock’s Grandmaster Composite Score of 0.75 reflects a strong overall technical and fundamental profile. UAL’s Bear Market Shield, at 0.36, means it fell 64.34% less than the S&P 500 during past market corrections, a rare quality that highlights its relative resilience in downturns.

D. Competitive Moat & Key Risk — The Honest Assessment Every Serious Investor Needs
United Airlines Holdings, Inc. maintains a substantial competitive moat primarily through its extensive global route network and the deeply entrenched MileagePlus® loyalty program. UAL’s network, spanning North America, Europe, Asia, and other continents, represents a significant barrier to entry due to the immense capital, regulatory approvals, and bilateral agreements required to replicate. This global reach, particularly its widebody operations, is structurally critical for high-margin international and cargo services. The MileagePlus program further enhances this moat by creating high switching costs for frequent flyers, offering benefits like Premier® Status and priority services that are difficult to forgo. Loyalty revenue growth of 13% year-over-year in Q1 2026 underscores its value. Compared to competitors like Delta or American, UAL’s specific hub strengths in markets like Chicago, Denver, Houston, and San Francisco provide distinct advantages for trans-Pacific and transatlantic routes. The primary risk that could invalidate a bullish thesis on UAL is a sustained, unexpected surge in jet fuel prices combined with a global economic slowdown. While UAL has demonstrated robust revenue growth, a sharp increase in its largest variable cost, coupled with reduced demand for both business and leisure travel, would severely compress its 30.1% gross margin and profitability. This scenario would directly challenge the company’s ability to maintain its growth trajectory and could materialize within the next 12-18 months if geopolitical tensions escalate or a significant recession takes hold, creating an unfavorable Asymmetric Risk-Reward Optimization.

E. The Trade Blueprint — Entry, Exit, and Position Sizing (If You Choose to Act)
UAL currently trades at $126.00, with a suggested portfolio weight of 1.45%. This sizing reflects a balanced approach within a diversified Hedge Fund Portfolio Allocation, acknowledging UAL’s robust fundamental performance alongside its quantitative signals. A critical exit strategy is the Chandelier Exit price of $118.62. If UAL’s price closes below $118.62 for two consecutive trading days, an immediate exit is warranted, without debate, to cap the maximum potential loss at -5.86%. For this trade to reach its full potential, three specific conditions must align. First, United Airlines must continue to demonstrate strong operational execution, specifically by expanding its premium cabin offerings like United Polaris and maintaining the growth trajectory of its MileagePlus program, which drives higher-margin revenue. Second, the broader airline sector needs to sustain its recovery, with stable fuel prices and consistent passenger demand across both leisure and business segments. Third, the overall market environment must remain supportive, characterized by investor appetite for cyclical growth stocks and a continued rotation into industries benefiting from global economic expansion. While UAL presents a high-probability setup given its strong Q1 2026 results and positive analyst sentiment, no trade is guaranteed.

⚠️ CRITICAL REGULATORY RISK NOTICE: This proprietary risk infrastructure framework is an absolute control safeguard designed to prevent terminal capital depletion and catastrophic drawdown. Upon asset price breaching or violating these mathematical exit parameters, institutional risk management dictates an immediate, non-discretionary capital reclamation and portfolio rebalancing sequence.

A. The Signal — Why Our Scanner Flagged UNH Today
UnitedHealth Group (UNH) registered a perfect 1.00 for its On-Balance Volume Accumulation Slope, indicating persistent institutional buying pressure beneath the surface. Out of over 6,000 stocks screened, UNH triggered a flag due to a powerful combination of its exceptional relative strength, robust technical posture, and significant institutional interest. The stock’s 6-Month Relative Strength Percentile stands at 0.76, placing it among the top quartile of all equities, a level fewer than 60 S&P 500 stocks achieve on any given day. This strong relative performance is complemented by a near-perfect 1.00 Technical Score, reflecting a highly constructive price chart. Furthermore, the Institutional Crowding score of 78.55 highlights substantial smart money participation. UNH’s Final Quant Score of 0.79 and a Grandmaster Composite Score of 0.84 position it in the top decile of all analyzed stocks, signaling a high-conviction setup. This combination suggests that UNH exhibits characteristics of a stock under quiet accumulation, poised for potential upside. The Premium Quant Signal Efficiency is detecting a confluence of factors that historically precede significant price advances, indicating a stock with strong underlying momentum despite its current consolidation. Our scanner is detecting a stock where consistent demand is absorbing available supply, setting the stage for a potential upward move.

B. The Business — What UNH Actually Does and Why This Moment Is Structurally Different
UnitedHealth Group Incorporated provides health benefit plans and technology-driven healthcare services through its UnitedHealthcare and Optum segments. Optum Health is currently driving the highest revenue growth, generating $105.4 billion in gross revenue in 2024, representing 19% of the company’s overall sales. This segment delivers comprehensive, patient-centered care through its medical groups and clinics, focusing on value-based care models. Its customers are individuals seeking integrated healthcare, from primary care to behavioral health, and healthcare systems looking to improve patient outcomes and efficiency. The broader macro tailwind for Optum Health is the accelerating shift towards value-based care within the U.S. healthcare system, a market projected to reach $1.5 trillion by 2027. This structural shift rewards providers for health outcomes rather than just service volume, aligning perfectly with Optum Health’s model. Despite these strong fundamentals, UNH’s Institutional Crowding score of 78.55, while significant, suggests that the Asset Management Matrix has not yet fully priced in the long-term implications of this strategic positioning. The Relative Strength Index (RSI-14) of 62.93 indicates the stock is not yet overbought, leaving room for further appreciation as the market recognizes the full potential of its diversified healthcare offerings.

UNH has outperformed 76.04% of all US stocks over the past six months, a robust relative strength rank that historically precedes sustained institutional accumulation. The stock exhibits a strong Volatility Contraction Pattern score of 0.78, indicating significant price coiling and energy building within its structure. This pattern suggests that seller supply is being absorbed, preparing for a potential expansion. Further supporting this, the On-Balance Volume Accumulation Slope registers a perfect 1.00, signaling aggressive smart money inflows and accumulation. While the Volume Dry-Up score is 0.37, it still points to some degree of seller exhaustion, contributing to the supply vacuum necessary for upward movement. UNH’s Grandmaster Composite Score stands at 0.84, reflecting a confluence of favorable technical and fundamental factors. The stock’s residual score, at 0.40, indicates it has demonstrated resilience during market corrections, a rare quality that often attracts institutional capital seeking defensive growth. This resilience, combined with the strong relative strength and accumulation, paints a clear picture of a stock under significant institutional interest.

D. Competitive Moat & Key Risk — The Honest Assessment Every Serious Investor Needs
UnitedHealth Group’s competitive moat is primarily built on its vast scale, intricate regulatory expertise, and the integrated nature of its Optum segment. The company’s sheer size in both health benefits (UnitedHealthcare) and healthcare services (Optum) creates significant economies of scale, allowing for more favorable negotiations with providers and pharmaceutical companies than smaller rivals. Regulatory complexity in the U.S. healthcare system acts as a substantial barrier to entry; UNH’s deep experience navigating these shifting landscapes is a critical, hard-to-replicate asset. The integration of Optum, which combines care delivery, pharmacy benefits, and data analytics, creates powerful network effects and high switching costs for clients. This comprehensive ecosystem, spanning health plans, care delivery, and technology, is a distinct advantage over competitors like Elevance Health or Cigna, which lack Optum’s integrated breadth. Replicating this full-stack model would require immense capital, regulatory approvals, and years to build trust and data infrastructure. The primary risk to UNH’s bull thesis is a significant shift in U.S. healthcare policy towards a single-payer system or aggressive government price controls on services and pharmaceuticals. Such a policy change, while politically challenging, would directly undermine the profitability of both UnitedHealthcare’s managed care offerings and Optum’s pharmacy benefit management and care delivery models. The probability of a full single-payer system being enacted within the next 2-3 years is low, but incremental steps toward greater government intervention, such as expanding Medicare Advantage direct negotiation powers or capping PBM profits, carry a moderate probability (30-40%) and could compress margins. Investors should consider this Asymmetric Risk-Reward Optimization when evaluating UNH’s long-term prospects.

E. The Trade Blueprint — Entry, Exit, and Position Sizing (If You Choose to Act)
UnitedHealth Group currently trades at $424.62. A suggested portfolio weight of 2.94% aligns with a disciplined Hedge Fund Portfolio Allocation strategy, reflecting UNH’s Grandmaster Composite Score of 0.84 and strong OBV Accumulation Slope of 1.00. This sizing acknowledges the stock’s robust fundamentals and institutional crowding score of 78.55, indicating significant professional interest. The Chandelier Exit is set at $404.85. If UNH’s price closes below this level for two consecutive days, an immediate exit is warranted, without debate. This hard stop limits the maximum loss to -4.65%, preserving capital. For this trade to reach its full potential, three specific conditions must materialize. First, UnitedHealth Group must continue to demonstrate robust growth in its Optum segment, particularly Optum Health, by successfully expanding its value-based care models and integrating new acquisitions, driving consistent earnings per share growth of 0.70. Second, the broader healthcare sector must maintain its defensive appeal and avoid significant legislative headwinds that could disrupt established managed care and PBM business models. Third, the overall market environment needs to support large-cap, quality-oriented names, with institutional capital continuing to flow into established leaders like UNH, as indicated by its high institutional crowding. While UNH presents a high-probability setup given its strong relative strength percentile of 0.76 and perfect score for the OBV Accumulation Slope, no trade is guaranteed. Vigilant monitoring of both price action and the underlying business fundamentals remains crucial.

⚠️ CRITICAL REGULATORY RISK NOTICE: This proprietary risk infrastructure framework is an absolute control safeguard designed to prevent terminal capital depletion and catastrophic drawdown. Upon asset price breaching or violating these mathematical exit parameters, institutional risk management dictates an immediate, non-discretionary capital reclamation and portfolio rebalancing sequence.

A. The Signal — Why Our Scanner Flagged ANET Today
Arista Networks (ANET) exhibits a near-perfect OBV Accumulation Slope of 1.00, indicating intense institutional buying pressure beneath the surface. Out of over 6,000 stocks screened, ANET’s combination of a robust Final Quant Score of 0.77 and a Grandmaster Composite Score of 0.70 triggered this flag. This composite score places ANET among a select group, with fewer than 60 S&P 500 stocks achieving this level of overall quantitative strength on any given day. The company’s 6-Month RS Percentile of 0.86, coupled with a Leader Score of 0.94, highlights its significant outperformance against the broader market and its sector peers. Furthermore, a Double Bottom Pattern score of 0.83 suggests a strong technical foundation, indicating a potential reversal from a prior downtrend. This confluence of signals, particularly the strong accumulation and relative strength, points to a stock experiencing significant underlying demand. The Premium Quant Signal Efficiency is detecting a powerful shift in institutional sentiment and positioning for ANET. The quant signal is detecting a robust accumulation phase and strong relative price performance, suggesting a stock poised for continued upward momentum.

B. The Business — What ANET Actually Does and Why This Moment Is Structurally Different
Arista Networks, Inc. designs and sells multi-layer network switches and software built upon its Extensible Operating System (EOS). The company’s Data Center and AI Switching Platforms are currently driving the highest revenue growth, exemplified by the new 1.6 Terabit (Tbps) networking platform specifically designed for rack-scale AI infrastructure. Arista reported Q1 2026 revenue of $2.71 billion, marking a substantial 35.1% year-over-year growth. Its primary customers are hyperscale cloud providers like Meta, Microsoft, and Oracle, along with large enterprises, all seeking to build and scale next-generation AI and cloud data centers that demand unparalleled network speed and efficiency. The market for AI infrastructure networking is experiencing a significant tailwind, with Arista’s campus networking segment alone projected to contribute around $1.25 billion in revenue for 2026. Despite a high Institutional Crowding score of 89.40, indicating substantial institutional interest, the RSI-14 of 59.39 suggests the stock is not yet overbought, implying that the market has not fully priced in the structural shift towards AI-driven networking demand. The Asset Management Matrix indicates continued opportunity for capital appreciation.

C. The Chart — What the Price Action Reveals About Institutional Behavior
ANET has outperformed 86.46% of all US stocks over six months, a rank that historically precedes institutional accumulation. The stock exhibits a strong double bottom pattern, scoring 0.83, indicating a “W” shaped recovery with two distinct troughs and an intervening peak. This pattern often signals a reversal from a downtrend. Despite this, the volatility contraction pattern score is 0.00, suggesting ANET’s price has not yet coiled tightly, meaning the spring is not yet compressed for a potential release. Similarly, the volume dry-up score of 0.28 indicates that seller supply has not been fully exhausted, preventing a complete supply vacuum. However, the on-balance volume accumulation slope is near-perfect at 1.00, signaling robust smart money flow into ANET. This strong buying pressure suggests institutions are actively accumulating shares. ANET’s residual score of 0.25 means it fell 75% less than the S&P 500 during past market corrections, a rare quality demonstrating significant defensive strength. The stock’s relative strength line is not yet making new 52-week highs, scoring 0.40, indicating it is lagging slightly in this powerful early-stage signal.

D. Competitive Moat & Key Risk — The Honest Assessment Every Serious Investor Needs
Arista Networks’ competitive moat is primarily built on its Extensible Operating System (EOS) and its deep integration with hyperscale cloud providers. EOS offers a highly programmable, resilient, and open architecture, creating significant switching costs for large customers who have invested in customizing and integrating it into their complex data center environments. The company’s focus on high-performance, low-latency networking solutions for AI and cloud infrastructure, exemplified by its 1.6Tbps and 800GbE platforms, positions it ahead of many competitors in a rapidly evolving segment. While Cisco remains a formidable competitor across the broader networking landscape, Arista’s specialized focus and superior performance in cloud and AI data centers provide a distinct advantage. Juniper Networks and Hewlett Packard Enterprise also compete, but Arista’s market share with hyperscalers demonstrates a wider moat in this specific, high-growth niche. The primary risk that could invalidate the bull thesis for Arista is a significant deceleration or shift in capital expenditure by its largest cloud titan customers, particularly if they opt to develop more in-house networking hardware or software solutions. Given the concentration of revenue from two major customers, any substantial reduction in their spending or a pivot in their technology strategy could severely impact Arista’s growth trajectory. The probability of this occurring in the next 12-18 months is moderate, as hyperscalers continuously evaluate build-versus-buy decisions. This scenario underscores the importance of Asymmetric Risk-Reward Optimization in evaluating ANET.

E. The Trade Blueprint — Entry, Exit, and Position Sizing (If You Choose to Act)
Arista Networks currently trades at $186.96. A suggested portfolio weight of 1.61% reflects a balanced approach, considering the stock’s strong fundamentals and institutional crowding score of 89.40, while acknowledging its volatility. The Chandelier Exit is set at $176.44; if ANET closes below this price for two consecutive days, an immediate exit is warranted, limiting the maximum loss to -5.63%. This strict adherence to the exit price is crucial for capital preservation. For this trade to reach its full potential, three specific conditions must materialize. First, ANET’s relative strength percentile, currently at 0.86, must continue its upward trajectory, ideally reaching a new 52-week high, signaling sustained outperformance. Second, the broader Technology sector, specifically the COMPUTER COMMUNICATIONS EQUIPMENT industry, needs to maintain its bullish momentum, providing a tailwind for ANET’s growth. Third, the overall market environment must remain supportive, with major indices showing continued strength, preventing a systemic downturn that could drag down even strong performers. The stock’s near-perfect OBV accumulation slope of 1.00 and a strong Leader Score of 0.94 indicate significant institutional interest. This setup, while high-probability, is not guaranteed, and position sizing, as guided by Hedge Fund Portfolio Allocation principles, is essential for managing risk effectively.

⚠️ CRITICAL REGULATORY RISK NOTICE: This proprietary risk infrastructure framework is an absolute control safeguard designed to prevent terminal capital depletion and catastrophic drawdown. Upon asset price breaching or violating these mathematical exit parameters, institutional risk management dictates an immediate, non-discretionary capital reclamation and portfolio rebalancing sequence.

A. The Signal — Why Our Scanner Flagged PSX Today
Phillips 66 exhibits a near-perfect 20-day win rate of 1.00, indicating exceptional short-term price consistency. Out of over 6,000 stocks screened, PSX triggered our Premium Quant Signal Efficiency due to a potent combination of signals. The stock’s 6-month relative strength percentile stands at 0.84, placing it among the top 16% of all equities, a level achieved by fewer than 60 S&P 500 stocks on any given day. This formidable relative strength is complemented by an OBV Accumulation Slope of 0.99, suggesting aggressive institutional buying pressure beneath the surface. Furthermore, the stock boasts a perfect technical score of 1.00, driven by its robust price action. While the Volatility Contraction Pattern score is low at 0.00, the Grandmaster Composite Score of 0.70 and a Final Quant Score of 0.76 signal a high-conviction setup. These scores indicate PSX is in the top quartile of our universe for overall quantitative attractiveness, suggesting a stock with strong underlying momentum and accumulation. The quant signal detects a significant shift in supply-demand dynamics, positioning PSX for potential upside.

B. The Business — What PSX Actually Does and Why This Moment Is Structurally Different
Phillips 66 refines crude oil into products like gasoline, distillates, and aviation fuels, alongside manufacturing lubricants and operating branded fuel stations. The Marketing and Specialties segment is currently driving the highest revenue growth for Phillips 66, reporting $84.12 billion in the trailing twelve months ending March 31, 2026. This segment serves a diverse customer base, including individual motorists at branded fuel stations, commercial fleets requiring lubricants, and wholesale distributors of specialized petroleum products, all seeking reliable energy and lubrication solutions. The broader energy market, particularly in refined products and specialty chemicals, continues to benefit from global demand expansion, with the transportation and petrochemical sectors representing a multi-trillion dollar addressable market annually. Despite PSX’s strong fundamentals, its Institutional Crowding score of 37.95 suggests that large asset managers have not yet fully allocated capital, indicating significant room for increased institutional ownership. The stock’s RSI-14 at 78.66, while elevated, points to strong buying interest that the Asset Management Matrix has not yet fully priced into its long-term models.

C. The Chart — What the Price Action Reveals About Institutional Behavior
PSX has outperformed 84.38% of all US stocks over six months, a rank that historically precedes institutional accumulation. The Volatility Contraction Pattern score of 0.00 indicates PSX is not currently exhibiting a tight price coil, suggesting less energy building for an immediate breakout. Furthermore, the Volume Dry-Up score of 0.14 points to minimal seller exhaustion, implying that a supply vacuum has not yet fully formed. However, the On-Balance Volume Accumulation Slope, at a near-perfect 0.99, demonstrates robust smart money flow into PSX, signaling strong institutional interest. The stock’s current price of 188.36 sits 0.07% above its 50-day moving average. PSX’s technical score is a perfect 1.00, indicating a strong technical posture. The Leader Score of 0.97 further reinforces its market leadership. The stock’s Bear Market Shield score of 0.81 reveals a rare quality: PSX historically fell 19% less than the S&P 500 during past market corrections, showcasing its defensive characteristics. This resilience, combined with significant institutional accumulation, positions PSX favorably within the Energy sector.

D. Competitive Moat & Key Risk — The Honest Assessment Every Serious Investor Needs
Phillips 66 establishes its competitive moat through an integrated downstream portfolio, spanning refining, midstream, chemicals, and marketing. This diversification mitigates segment-specific volatility, a structural advantage over pure-play refiners or chemical companies. The company’s extensive midstream infrastructure, including pipelines and terminals, represents a significant barrier to entry due to high capital requirements and regulatory hurdles. Furthermore, its 50% equity stake in Chevron Phillips Chemical Company LLC provides access to proprietary petrochemical technologies and global market reach that would be costly and time-consuming for competitors to replicate. Compared to competitors like Valero Energy or Marathon Petroleum, Phillips 66’s broader chemicals and specialties footprint offers a wider, more resilient earnings base. The company’s brand recognition in fuels and lubricants, through names like Phillips 66, Conoco, and Kendall, also fosters customer loyalty and provides pricing power in certain markets. For serious investors, this integrated model is critical for Asymmetric Risk-Reward Optimization. The primary risk that could invalidate the bull thesis for Phillips 66 is a sustained, severe global economic recession leading to a dramatic and prolonged decline in demand for refined products and petrochemicals. Unlike typical cyclical downturns, this scenario would involve a structural shift away from current energy consumption patterns, severely impacting refining margins, chemical product demand, and midstream throughput. The probability of such a severe, sustained recession within the next 12-18 months is moderate, but its impact would be profound, eroding profitability across all segments simultaneously.

E. The Trade Blueprint — Entry, Exit, and Position Sizing (If You Choose to Act)
Phillips 66 currently trades at $188.36. A suggested portfolio weight of 2.64% is appropriate for this setup, reflecting a balanced approach to Hedge Fund Portfolio Allocation, considering the stock’s overall quant score of 0.76 and a Grandmaster Composite Score of 0.70. This sizing allows for meaningful participation while managing risk exposure within a diversified portfolio. The Chandelier Exit price is $179.49. If Phillips 66 closes below this level for two consecutive trading days, an immediate exit is warranted, regardless of other market conditions. This hard stop limits the maximum loss to -4.71% from the current price, preserving capital. For this trade to reach its full potential, three specific conditions must align. First, Phillips 66’s refining margins must remain robust, supported by favorable crack spreads and efficient operations, indicating strong internal business performance. Second, the broader energy sector, particularly petroleum refining, needs to maintain its current momentum, with industry-specific tailwinds like stable crude oil prices and healthy demand. Third, the overall market environment must remain constructive, avoiding a broad-based risk-off sentiment that could indiscriminately drag down even strong individual equities. While Phillips 66 presents a high-probability setup based on its strong technicals, including a near-perfect OBV Accumulation Slope of 0.9977 and a perfect Score Tech of 1.00, no trade is guaranteed.

⚠️ CRITICAL REGULATORY RISK NOTICE: This proprietary risk infrastructure framework is an absolute control safeguard designed to prevent terminal capital depletion and catastrophic drawdown. Upon asset price breaching or violating these mathematical exit parameters, institutional risk management dictates an immediate, non-discretionary capital reclamation and portfolio rebalancing sequence.

FREE DAILY SIGNAL

Get Tomorrow’s Top 5 Picks in Your Inbox

Today we flagged LLY, UAL, UNH & more — all ranked top 5% of 6,000+ US equities.
Get the next briefing delivered before market open, every trading day. No spam. No cost. Unsubscribe anytime.

📬 Subscribe — Get Tomorrow’s Picks Free →

Published every trading day · July 11, 2026 · Quant Signal Lab

📋 Related Quant Analysis — Previous Daily Briefings

Our algorithm screens 6,000+ US equities daily. Browse past signals below:

• → TXN Stock Analysis: Momentum Breakout Signal — Top 5 Institutional Leaders for | TXN, ETSY, VLO, EBAY, ABB
• → MU Stock Analysis: Momentum Breakout Signal — Top 5 Institutional Leaders for | MU, D, AEP, NXPI, DUK
• → MPC Stock Analysis: Momentum Breakout Signal — Top 5 Institutional Leaders for | MPC, SNOW, SBUX, JNJ, DE
• → AMD Stock Analysis: Momentum Breakout Signal — Top 5 Institutional Leaders for | AMD, CRWD, CSCO, PANW, MR
• → AMAT Stock Analysis: Momentum Breakout Signal — Top 5 Institutional Leaders for | AMAT, KLAC, INTC, CAT, N

New report published every trading day.  

View all quant stock reports →

Frequently Asked Questions

Our Verdict on Today’s 5 Picks

Our algorithm scanned >6,000 US stocks today and these 5 rose to the top — not because of narrative, but because all 7 quantitative signals aligned simultaneously: momentum, institutional accumulation, volatility contraction, volume dry-up, downside resilience, ML layer confirmation, and bear-market shield. That kind of multi-factor convergence is rare. Fewer than 0.08% of stocks in our universe achieve this level of signal alignment on any given day.

The one rule that separates profitable traders from everyone else: every pick above comes with a mathematically defined exit price — a specific dollar level where the trade thesis is invalidated. Use it without emotion. The single most destructive behavior in retail investing is holding a losing position beyond its stop-loss while hoping for a reversal. The Chandelier Exit levels above are not suggestions. They are hard stops.

What to watch this week: Monitor whether each pick holds above its 20-day moving average during any broad market pullback. Stocks that hold while the market dips are showing genuine institutional support. Stocks that break down with the market are showing you they were riding beta, not alpha. That distinction reveals everything about which setups have real follow-through potential.

These are high-probability setups grounded in quantitative data — not guaranteed outcomes. Come back tomorrow — the list refreshes with each market session as new data updates every factor. Bookmark this page and share it with one investor who deserves a better signal.

💡 Strategic Allocation Note for Active Retail Traders:
The recommended portfolio weights calculated above (e.g., 3.385%) are strictly derived from institutional Risk Parity Models designed for large-scale multi-million dollar funds to achieve zero-crash behavior.
Individual active traders focusing on a highly concentrated portfolio (typically 5 to 10 stocks) should treat these percentages as relative conviction ratios rather than absolute capital caps. You may scale up these mathematical proportions proportionally to meet your specific active capital allocation and compounding targets.

Source: Quant Signal Lab | Data: Polygon.io | Charts: Finviz | Copyright © 2026 Premium Financial Research. All rights reserved.

Keywords: Today’s top 5 momentum stocks: LLY, UAL, UNH, ANET, PSX. Proprietary 7-factor quant model screens 6,000+ US equities daily. Entry signals, risk levels & se